ReachMD

Be part of the knowledge.™

Pathology and Laboratory Medicine

97

LikeLikedUnlike

Episodes 1-15 of 17

- Maria E. Arcila, MD
  Peer
- Alexander Drilon, MD
  Peer
0
CME/CE
Practicing Precision in ALK and ROS1 Rearrangement Positive NSCLC: Testing, Targets, and Treatments
Practicing Precision in ALK and ROS1 Rearrangement Positive NSCLC: Testing, Targets, and Treatments
1.00 credits
- D. Ross Camidge, MD, PhD
  Peer
3
CME/CE
Improving the Quality of Care for Patients Harboring ALK+ NSCLC
Improving the Quality of Care for Patients Harboring ALK+ NSCLC
0.50 credits
- Julien Taieb, MD, PhD
  Peer
- Scott Kopetz, MD, PhD
  Peer
5
CME/CE
Optimizing Treatment and Patient Selection in BRAF V600E-Mutated Metastatic Colorectal Cancer
Optimizing Treatment and Patient Selection in BRAF V600E-Mutated Metastatic Colorectal Cancer
0.25 credits
- Daniel Catenacci, MD
  Peer
- Yelena Janjigian, MD
  Peer
5
CME/CE
Applying Clinical Evidence in Advanced HER2-Positive Gastric Cancer
Applying Clinical Evidence in Advanced HER2-Positive Gastric Cancer
0.25 credits
- Richard T. Penson, MD, MRCP
  Peer
- Ana Oaknin, MD
  Peer
3
CME/CE
Keeping Pace in Women’s Cancer: Clinical Considerations for Endometrial Cancer—Global Perspectives
Keeping Pace in Women’s Cancer: Clinical Considerations for Endometrial Cancer—Global Perspectives
0.25 credits
- Richard T. Penson, MD, MRCP
  Peer
- Nicoletta Colombo, MD
  Peer
- Christine Ghione
  Peer
5
CME/CE
Keeping Pace in Women’s Cancer: Targeting Advanced Endometrial Cancer
Keeping Pace in Women’s Cancer: Targeting Advanced Endometrial Cancer
0.25 credits
- Robert Mocharnuk, MD
  Peer
- Johann de Bono, MB, ChB FRCP, MSc, PhD, FMedSci
  Peer
- Neeraj Agarwal, MD
  Peer
3
CME/CE
Pulse Points in Prostate Cancer: Embracing Advances with PARPi Combinations
Pulse Points in Prostate Cancer: Embracing Advances with PARPi Combinations
0.75 credits
- Monica L. Baskin, PhD
  Peer
- Josep M. Llovet, MD, PhD
  Peer
3
CME/CE
Advocating for Action in HCC: Delivering Impartial and Personalized Care
Advocating for Action in HCC: Delivering Impartial and Personalized Care
1.00 credits
- Federico Cappuzzo
  Peer
- Professor Solange Peters
  Peer
- Professor Yi-Long Wu
  Peer
4
CME/CE
The Latest Clinical Considerations for Non-Small Cell Lung Cancer: A Global Approach
The Latest Clinical Considerations for Non-Small Cell Lung Cancer: A Global Approach
0.25 credits
- Peter Schmid, FRCP, MD, PhD
  Peer
- Javier Cortes, MD, PhD
  Peer
6
CME/CE
Keeping Pace in Women’s Cancers: Updates in Triple-Negative Breast Cancer
Keeping Pace in Women’s Cancers: Updates in Triple-Negative Breast Cancer
0.25 credits
- Jennifer W. Carlisle, MD
  Peer
- Suresh S. Ramalingam, MD
  Peer
7
CME/CE
An Evolving Clinical Landscape in HER2+ and HER2-Mutant Metastatic NSCLC: Critical Updates for Your Practice
An Evolving Clinical Landscape in HER2+ and HER2-Mutant Metastatic NSCLC: Critical Updates for Your Practice
0.50 credits
- Jeffrey S. Weber, MD, PhD
  Peer
5
CME/CE
Kimberly’s Concerning Mole: Exploring First-Line Treatment Strategies for Patients with Advanced Metastatic Melanoma
Kimberly’s Concerning Mole: Exploring First-Line Treatment Strategies for Patients with Advanced Metastatic Melanoma
0.25 credits
- Robert Mocharnuk, MD
  Peer
- Pelin Cinar, MD, MS
  Peer
- Malika Fair, MD, MPH, FACEP
  Peer
8
CME/CE
The COVID-19 Chronicles: Real-World Perspectives on Cancer Care, Emergency Medicine and Healthcare Disparities
The COVID-19 Chronicles: Real-World Perspectives on Cancer Care, Emergency Medicine and Healthcare Disparities
1.00 credits
- Stephen M. Cohen, MD, FACOG
  Peer
- Thomas C. Wright, Jr., MD
  Peer
18
CME/CE Broadcast Replay
Advances in Cervical Cancer Screening
Advances in Cervical Cancer Screening
0.50 credits
- Karen Reckamp, MS, MD
  Peer
- Heather Wakelee, MD
  Peer
6
CME/CE
Optimizing Patient Outcomes in Advanced NSCLC in a Rapidly Evolving Treatment Era
Optimizing Patient Outcomes in Advanced NSCLC in a Rapidly Evolving Treatment Era
1.00 credits

Segment Chapters

Playlist:

Recommended